These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 25591984

  • 1. Metabolic risk in PCOS: phenotype and adiposity impact.
    Moran LJ, Norman RJ, Teede HJ.
    Trends Endocrinol Metab; 2015 Mar; 26(3):136-43. PubMed ID: 25591984
    [Abstract] [Full Text] [Related]

  • 2. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E.
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [Abstract] [Full Text] [Related]

  • 3. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [Abstract] [Full Text] [Related]

  • 4. Adiposity and metabolic dysfunction in polycystic ovary syndrome.
    Sam S.
    Horm Mol Biol Clin Investig; 2015 Feb; 21(2):107-16. PubMed ID: 25781555
    [Abstract] [Full Text] [Related]

  • 5. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM, Reeves S.
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [Abstract] [Full Text] [Related]

  • 6. Cardiometabolic and reproductive benefits of early dietary energy restriction and voluntary exercise in an obese PCOS-prone rodent model.
    Diane A, Kupreeva M, Borthwick F, Proctor SD, Pierce WD, Vine DF.
    J Endocrinol; 2015 Sep; 226(3):193-206. PubMed ID: 26187902
    [Abstract] [Full Text] [Related]

  • 7. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M, Spiazzi G, Zanolin ME, Bonora E.
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
    [Abstract] [Full Text] [Related]

  • 8. The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome.
    Barber TM, Vojtechova P, Franks S.
    Horm Mol Biol Clin Investig; 2013 Sep; 15(3):91-103. PubMed ID: 25436736
    [Abstract] [Full Text] [Related]

  • 9. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Sep; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 10. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC, Guarnotta V, Forti D, Donatelli M, Dolcimascolo S, Giordano C.
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [Abstract] [Full Text] [Related]

  • 11. Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity.
    Chiu WL, Boyle J, Vincent A, Teede H, Moran LJ.
    Neuroendocrinology; 2017 Jul; 104(4):412-424. PubMed ID: 28006770
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS.
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.
    Shorakae S, Boyle J, Teede H.
    Intern Med J; 2014 Aug; 44(8):720-6. PubMed ID: 24909750
    [Abstract] [Full Text] [Related]

  • 15. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK, Mário FM, Alves BC, Spritzer PM.
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [Abstract] [Full Text] [Related]

  • 16. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
    van Houten EL, Visser JA.
    Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
    [Abstract] [Full Text] [Related]

  • 17. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM.
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.
    Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M.
    Gynecol Endocrinol; 2014 Jun; 30(6):397-402. PubMed ID: 24552422
    [Abstract] [Full Text] [Related]

  • 19. Periodontal disease in polycystic ovary syndrome.
    Dursun E, Akalın FA, Güncü GN, Çınar N, Aksoy DY, Tözüm TF, Kılınc K, Yıldız BO.
    Fertil Steril; 2011 Jan; 95(1):320-3. PubMed ID: 20800834
    [Abstract] [Full Text] [Related]

  • 20. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.